scholarly journals Glycopeptide intermediate resistant Staphylococcus aureus

2002 ◽  
Vol 6 (21) ◽  
Author(s):  
B Cookson

Last week, the Public Health Laboratory Service in England reported an isolation of a glycopeptide resistant methicillin resistant Staphylococcus aureus (MRSA) (1). The organism was isolated from a patient with endocarditis who had failed to respond to treatment with this antibiotic used in combination with gentamicin and rifampicin.

2016 ◽  
Vol 78 (5) ◽  
Author(s):  
A. M. Setiawan

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most complicated problems in infection control and disease prevention. Imported strains or group of similar strains called clones were introduced from other states within Australia and also from other countries. Western Australia (WA) MRSA clones known to be the most predominant clones circulating in Western Australia (WA). However, MRSA strains originally from other states and countries outside Australia (imported) have increased in number in the last decades. The aim of this study was to examine the epidemiology of CA MRSA clones in Western Australia for the past 11 year’s period (2003-2013). There were 10 predominant clones of CA-MRSA circulating in WA with WA MRSA-1 (32,82%), Queensland (22,67 %) and WA MRSA-2 (22,67 %) clones as the top three predominant clones. The percentage of PVL positive CA-MRSA clones such as Queensland (Qld) clone has been increasing significantly (R2=0,67) from 2,38 % in 2002 to 25,69% in 2013. In contrast, the percentages of two major PVL negative clones, WA MRSA-1 and WA MRSA 2, have been decreasing nearly by half from 52,38 % to 27,71 % and 30,95 % to 16,59 % respectively in the last 11 years. PVL positive clones have been introduced in WA from other states and overseas in the last eleven years. Due to the virulence factor of PVL toxin, the emergence of PVL positive CA-MRSA should be considered as public health concerns.


2002 ◽  
Vol 6 (45) ◽  
Author(s):  
S O’Brien ◽  
L Ward

Although Salmonella Enteritidis phage type (PT) 4, responsible for the major epidemic during the late 1980s and early 1990s (1), has continued to decline, there have been increases in a number of the more unusual phage types of S. Enteritidis (2). Isolates of S. Enteritidis PT 3, 6a, 13a and 14b and 21 confirmed by the Public Health Laboratory Service Laboratory of Enteric Pathogens (PHLS LEP) in England have all increased during 2002 (table 1) (3).


Author(s):  
Jona Gjevori ◽  
Kahina Abdesselam

Methicillin-Resistant Staphylococcus aureus (MRSA) is among the most prevalent nosocomial pathogens globally, causing significant morbidity, mortality, and healthcare costs. MRSA bloodstream infection (BSI) incidence rates in Canadian hospitals have significantly risen by almost 60% and have a mortality of over 20% upon Intensive Care Unit admission. MRSA is believed to be spread through healthcare workers; thus, high hand hygiene compliancy in addition to environmental cleaning are the cornerstone countermeasures to disrupting its transmission. The Public Health Agency of Canada (PHAC), in collaboration with the Canadian Nosocomial Infection Surveillance Program (CNISP), conducts national, sentinel surveillance on healthcare-associated infections like MRSA. As a Student Epidemiologist, I developed a research proposal detailing two study objectives: 1) develop a regression model to predict all incident MRSA BSI rates among acute-care hospitals in Canada using CNISP MRSA BSI incident cases from 2000 to 2019, and 2) create a compartmental (Susceptible-Infected-Recovered-Deceased) model to determine the impact of various Infection Prevention and Control (IPC) measures on the risk of healthcare-associated MRSA BSI transmission specifically. This study hopes to demonstrate that proper IPC compliance is associated with lower incident MRSA BSI rates with the goal being to produce a manuscript draft by 2021. MRSA poses a serious threat to patient safety globally and is becoming a growing national public health concern in Canada; determining which IPC strategy is most effective at disrupting MRSA transmission is essential to reducing incidence and mortality rates.


Sign in / Sign up

Export Citation Format

Share Document